https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-01-06 17:27:132025-01-06 17:27:13Phase 2 Adaptive ADT and Docetaxel Trial for mCSPC
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-01-06 17:05:442025-01-06 17:05:44Phase 2 Trial Recruiting: WOMBAT Study on Bipolar Androgen Therapy for Prostate Cancer
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-01-04 21:04:532025-01-04 21:04:53Phase 1 Clinical Trial: The PHAROS Trial Investigates Novel ACK1 Inhibitor
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-01-04 14:27:032025-01-04 14:27:03Phase 1 trial results of KPG-121
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-01-04 14:08:302025-01-04 14:09:53PT217 Receives Second FDA Fast Track Designation for Neuroendocrine Prostate Cancer Treatment
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2025-01-02 08:29:182025-01-02 08:29:18Recent Advances in Tumor Reversion Research
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-30 15:46:152024-12-30 15:46:15Emerging Radiopharmaceuticals for Low PSMA-Expressing Prostate Cancer: 67Cu-SAR-bisFAP and 67Cu-SAR-bombesin
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
0
0
Max
https://prostatewarriors.com/wp-content/uploads/2024/10/prostate-warriors-logo-300x138.png
Max2024-12-30 09:27:272025-01-05 09:22:33Phase 1 Trial: Simple Dietary Supplement Could Supercharge Cancer-Fighting Immune Cells